Remove 2028 Remove Compliance Remove Pharmaceutical
article thumbnail

Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography

Frost & Sullivan Manufacturing

By enabling precise separation and analysis of complex mixtures, chromatography plays a crucial role in ensuring pharmaceutical purity, food safety, and environmental compliance. billion in 2028. With robust support and training, these technologies are also enhancing lab efficiency and return on investment (ROI).

article thumbnail

The Future of Healthcare Data Interoperability: Driving Seamless Data Exchange

Frost & Sullivan Manufacturing

billion by 2028 with a robust 18.3% billion by 2028, growing at 18.3% Evolving Regulations for Accessible Data : Introducing new mandates to ensure data is readily transferable between different stakeholders through common structure or application programming interfaces (APIs) and strict implementation to ensure nation-wide compliance.

article thumbnail

IntelGenx enters into feasibility & development agreement for VetaFilm™

Canadian Manufacturing

a manufacturer of pharmaceutical films, announced that it has entered into a Feasibility Study & Development Agreement with an undisclosed animal health company focused on advancing a VetaFilm -based oral film formulation containing CBD for use in companion animals. billion by 2028.”. SAINT LAURENT — IntelGenx Corp., to reach $4.79